NCT00890084已完成不适用
RESPECT: Observational, Prospective, Open-label, Multi-center Study Evaluating the Antihypertensive Effect of Treatment With Telmisartan (Alone or in Fixed Combination With HCTZ) in General Practitioner and Specialist Practice in Hypertensive Patients With High and Very High Cardiovascular Risk According to the ESH/ESC Guidelines 2007 Who Are Uncontrolled Under Current Treatment.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,913
- 主要终点
- Percentage of Patients With Blood Pressure < 140/90 mm Hg
研究概览
简要总结
To assess the efficacy of telmisartan in hypertensive patients with high cardiovascular risk
详细描述
Study Design:
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Group1
干预措施: Telmisartan or Telmisartan + Hydrochlorothiazide (HCTZ) (Drug)
结局指标
主要结局
Percentage of Patients With Blood Pressure < 140/90 mm Hg
时间窗: 12 weeks
% of high risk patients with Blood Pressure \< 140/90 mm Hg
次要结局
- Absolute Blood Pressure Decrease(baseline and 12 weeks)
- Change in Concomitant Antihypertensive Drugs Given at Study Entry(baseline and 12 weeks)
- Percentage of Patients With Blood Pressure < 130/80 mm Hg(12 weeks)
- BP Response Rate (Drop of Systolic BP of 10mmHg or More)(12 weeks)
- Treatment Patterns(12 weeks)
- Percentage of Patients in Whom the Prescriber Decide to Further Lower the Blood Pressure to < 130/80 mm Hg(12 weeks)
- Percentage of Prescribers Who Adhered to European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines 2007(12 weeks)
研究者
相似试验
已完成
不适用
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesObesityHypertensionNCT00539487Boehringer Ingelheim5,827
已完成
4 期
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential HypertensionHypertensionNCT02242370Boehringer Ingelheim3,045
已完成
3 期
BIBR 277 Capsule in Patients With Essential HypertensionHypertensionNCT02177448Boehringer Ingelheim225
已完成
不适用
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and PatientsHypertensionNCT02242851Boehringer Ingelheim5,018
已完成
不适用
Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®HypertensionNCT00927537Bayer2,052